131 related articles for article (PubMed ID: 2945811)
1. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
Lagast H; Dodion P; Klastersky J
J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
Van der Auwera P; Klastersky J
J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
[TBL] [Abstract][Full Text] [Related]
3. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
4. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
Odenholt I; Löwdin E; Cars O
Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
[TBL] [Abstract][Full Text] [Related]
6. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
Bailey EM; Rybak MJ; Kaatz GW
Antimicrob Agents Chemother; 1991 Jun; 35(6):1089-92. PubMed ID: 1834010
[TBL] [Abstract][Full Text] [Related]
7. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Barr JG; Smyth ET; Hogg GM
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model.
Pallanza R; Scotti R; Arioli V
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():15-21. PubMed ID: 2965127
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
[TBL] [Abstract][Full Text] [Related]
12. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
Clin Pharmacokinet; 2008; 47(12):793-805. PubMed ID: 19026035
[TBL] [Abstract][Full Text] [Related]
13. The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.
Chen HY; Williams JD
Eur J Clin Microbiol; 1984 Oct; 3(5):436-8. PubMed ID: 6238822
[TBL] [Abstract][Full Text] [Related]
14. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
[TBL] [Abstract][Full Text] [Related]
15. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
Cohen R; Barre J; Varon E
Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
[TBL] [Abstract][Full Text] [Related]
16. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
Barry AL; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
Van der Auwera P; Klastersky J
Antimicrob Agents Chemother; 1987 Jul; 31(7):1002-5. PubMed ID: 2959197
[TBL] [Abstract][Full Text] [Related]
18. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Van der Auwera P
Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]